TrueBinding

Also Clin2 stroke; TB101 RD oncology; 3 additional programs RD undisclosed

TrueBinding is a cutting-edge biotherapeutics company revolutionizing drug discovery through the development of monoclonal antibody therapeutics for neurodegenerative diseases, like Alzheimer’s disease and Dementia. Unlike current treatments that manage symptoms, TrueBinding aims to halt or even reverse the disease in order to make a lasting impact on those suffering from these challenging conditions. Although their focus has been neurodegernative diseases, they have expanded their applications to health conditions with unmet medical needs such as stroke, cancers, and other serious diseases. TrueBinding is dedicated to developing innovative treatments for these diseases with high unmet medical needs due to limited treatment options.

Jobs: